Welcome to our dedicated page for Lifeway Food news (Ticker: LWAY), a resource for investors and traders seeking the latest updates and insights on Lifeway Food stock.
Lifeway Foods, Inc. (NASDAQ: LWAY) is a U.S. manufacturer of probiotic, cultured and fermented dairy foods best known for its drinkable kefir, cheeses and ProBugs products for kids. This news page aggregates coverage of the company’s announcements, regulatory disclosures and shareholder communications so readers can follow developments affecting the LWAY stock and the underlying business.
Company news releases highlight Lifeway’s role as America’s leading supplier of the probiotic, fermented beverage known as kefir and as a leading U.S. supplier of kefir and fermented probiotic foods. Recent items include product innovation such as the planned launch of Probiotic Kefir Butter™, which extends the company’s cultured dairy expertise into spreadable European-style butter, as well as updates on sales trends and volume growth for its kefir portfolio.
Investors can also find governance and capital markets news, including details of a Cooperation Agreement with Danone North America PBC, board refreshment steps, amendments to a shareholder rights plan and proxy-related communications involving Institutional Shareholder Services and significant shareholders. These stories provide context on how Lifeway’s board structure, shareholder base and strategic options are evolving.
In addition, Lifeway’s news flow covers participation in investor conferences, commentary on federal dietary guidelines that reference kefir and fermented foods, and other corporate updates. By reviewing this page, readers can see how product initiatives, governance developments and financial disclosures intersect for Lifeway Foods, Inc. and its LWAY listing on the Nasdaq Global Market.
Lifeway Foods, a leader in probiotic products, reported a 16.1% increase in net sales year-over-year, reaching $34.1 million for Q1 2022. This marks the 10th consecutive quarter of sales growth, driven by strong demand for their drinkable Kefir and price increases. The company remains optimistic about future growth, focusing on expanding distribution in retail and away-from-home locations. However, the reporting of financial results faced delays, impacting the filing of their 10-K and 10-Q reports.
Lifeway Foods, Inc. (Nasdaq: LWAY) received a notice from Nasdaq on August 23, 2022, indicating non-compliance with Listing Rule 5250(c)(1) due to delayed filings of its Quarterly Reports for Q1 and Q2 of 2022. This follows an earlier notice about the untimely filing of its Annual Report for 2021. The Company must submit a compliance plan by September 7, 2022, potentially receiving an extension up to 180 days to file necessary reports. Lifeway is actively working to meet these requirements and regain compliance.
Lifeway Foods, Inc. (Nasdaq: LWAY) announced a strategic agreement with Edward and Ludmila Smolyansky on July 29, 2022. This agreement stabilizes Lifeway's board of directors and facilitates the nomination of several key individuals for election at the upcoming annual meeting on August 31, 2022. Julie Smolyansky, President and CEO, expressed optimism about the new board members and their alignment with the company's mission. The board will also review strategic alternatives to enhance company performance.
Lifeway Foods (LWAY) reports a 16.7% increase in annual net sales, totaling $119.1 million for the year ended December 31, 2021. This marks the 9th consecutive quarter of growth, driven by higher sales volumes of drinkable kefir and the acquisition of GlenOaks Farms. Although selling expenses rose to $11.1 million, Lifeway maintained a steady gross profit margin of 24.1%. The company encountered delays in financial reporting due to an accounting error related to a past acquisition, necessitating restatements for prior periods.
Lifeway Foods (LWAY) announced receiving a Nasdaq notice indicating non-compliance with Rule 5250(c)(1) due to late filing of its 10-Q for Q1 2022 and previously for its 10-K for 2021. The Company must submit a compliance plan by June 20, 2022, to potentially regain compliance by October 12, 2022. Despite these issues, the Nasdaq notice has no immediate effect on LWAY's stock listing. Lifeway is actively working on its filings and aims to resolve the compliance issues promptly.
Lifeway Foods (LWAY) is launching a charity relief bottle, directing 100% of profits, up to $1 million, to support humanitarian aid for Ukraine. This initiative builds on their ongoing efforts, including a fundraiser that raised $700,000 for World Central Kitchen. Lifeway’s Plain Whole Milk Kefir will be the flagship product, expected on shelves in June. The company emphasizes its commitment to humanitarian support and collaboration with various organizations to aid Ukraine, reflecting its Ukrainian heritage and mission to help those in need.
Lifeway Foods (Nasdaq: LWAY) announced the filing of preliminary proxy materials for its 2022 Annual Meeting of Shareholders, revealing a slate of director nominees. The board proposes adding independent nominees, Perfecto Sanchez and JC Dalto, to enhance its leadership. CEO Julie Smolyansky highlighted their industry expertise and potential to add value. Lifeway's ongoing strategy has led to eight consecutive quarters of sales growth, with new product innovations like Lifeway Oat boosting retail acceptance. The company is committed to maintaining a diverse and skilled board for sustainable growth.
Lifeway Foods, Inc. (Nasdaq: LWAY) received a Nasdaq Notice dated April 19, 2022, indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) due to the late filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2021. The Company is required to submit a compliance plan within 60 days of the notice. If accepted, Nasdaq may grant an extension of up to 180 days to regain compliance. Lifeway is actively working to file the Form 10-K as soon as possible.
Lifeway Foods, Inc. (LWAY) will present its new probiotic oat beverages at the Natural Products Expo West 2022 from March 8-12 in Anaheim, CA. Featured products include the Lifeway Organic Oat, a NEXTY Award finalist, and the Lifeway MSHRM Oat™, an adaptogenic mushroom drink. Attendees can sample various flavors and learn about the health benefits of probiotics. CEO Julie Smolyansky emphasizes the company’s commitment to supporting gut health and immunity, especially as mental health is a growing concern.
Lifeway Foods, Inc. (Nasdaq: LWAY) announced a supportive response to a recent 13D filing, affirming CEO Julie Smolyansky's ongoing leadership and execution of the Lifeway 2.0 strategy. The independent Directors highlighted a track record of growth, marking eight consecutive quarters of year-over-year net sales increases. New product innovations, including the launch of Lifeway Oat and the acquisition of GlenOaks Farms for yogurt production, are expected to drive future growth. The Board remains committed to enhancing long-term shareholder value.